Add-On rTMS for Medication-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial in Chinese Patients
The DOI matches its Crossref record.
Abstract
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) has been developed as a novel tool for improving depression by delivering magnetic stimulation to the brain. However, the apparent effects of rTMS on depression have been varied in different studies. The aims of this study were to determine whether left dorsolateral prefrontal cortex rTMS can alleviate medication-resistant depression in Chinese patients and to investigate what demographic variables or clinical features may predict better response. METHOD: We designed a 2-week randomized, double-blind, sham-controlled study of add-on rTMS. A total of 30 medication-resistant patients with DSM-IV major depressive disorder or bipolar disorder, depressed episode completed 10 sessions of active or sham rTMS-10 patients at each of 2 frequencies, faster (20 Hz) or slower (5 Hz) at 100% motor threshold, and 10 patients at sham stimulation. RESULTS: Patients at both stimulation frequencies demonstrated a superior reduction of depression severity compared to sham stimulation (active = 55.7% vs. sham = 16.3%). The response rate for active rTMS was 60%, in contrast to 10% for the sham treatment. No difference in clinical response was observed between 5 Hz and 20 Hz active rTMS. Clinical variables showed that younger age and less severe depression at entry may predict the clinical response to rTMS. Except for 1 patient in which rTMS appeared to induce mania, this procedure posed no safety problem. CONCLUSIONS: To our knowledge, this is the first study to demonstrate the clinical efficacy and safety of rTMS in Chinese patients. Since not all the rTMS trials in previous reports had positive results, further larger trials are still warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119
Berlim, M. T., van den Eynde, F., Tovar-Perdomo, S., & Daskalakis, Z. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000512 · Cited by 620
“…et al. 2004; Koerselman et al. 2004; Response, remission and drop-out rates after HF-rTMS for major depression 227 Mosimann et al. 2004; Rossini et al. 2005; Su et al. 2005; Avery et al. 2006; Anderson et al. 2007; Loo et al. 2007; O’Reardon et al. 2007; Stern et al. 2007; Mogg et al. 2008).”
BackgroundInfluentialSlotema, C. W., Blom, J. D., Hoek, H. W., & Sommer, I. E. C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04872gre · Cited by 584
Brunoni, A. R., Chaimani, A., Moffa, A. H., Razza, L. B., Gattaz, W. F., Daskalakis, Z. J., & Carvalho, A. F. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3644 · Cited by 520
Gaynes, B. N., Lloyd, S. W., Lux, L., Gartlehner, G., Hansen, R. A., Brode, S., Jonas, D. E., Evans, T. S., Viswanathan, M., & Lohr, K. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08815 · Cited by 347
Lisanby, S. H., Husain, M. M., Rosenquist, P. B., Maixner, D., Gutierrez, R., Krystal, A., Gilmer, W., Marangell, L. B., Aaronson, S., Daskalakis, Z. J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.118 · Cited by 333
“…course of TMS (at least 4 weeks) provided in this study was more effective in achieving response in older patients than the 1–2 weeks provided in the previous trials that reported an age effect (Figiel et al, 1998; Fregni et al, 2006; Manes et al, 2001; Mosimann et al, 2002, 2004; Su et al, 2005).”
ResultLam, R. W., Chan, P., Wilkins-Ho, M., & Yatham, L. N. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300909 · Cited by 297
Loo, C. K., McFarquhar, T. F., & Mitchell, P. B. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007717 · Cited by 264
Berlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249
Brunoni, A. R., Lopes, M., Kaptchuk, T. J., & Fregni, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004824 · Cited by 173
“Su [65] 10 42.”
Razza, L. B., Moffa, A. H., Moreno, M. L., Carvalho, A. F., Padberg, F., Fregni, F., & Brunoni, A. R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.016 · Cited by 172
Avery, D. H., Isenberg, K. E., Sampson, S. M., Janicak, P. G., Lisanby, S. H., Maixner, D. F., Loo, C., Thase, M. E., Demitrack, M. A., & George, M. S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0315 · Cited by 129
“At least 2 controlled TMS studies allowing medications have found remission rates of 50% in medication-resistant depressed patients.(6,17) Interestingly, Haskett and colleagues(18) found that ECT patients randomly assigned to receive either nortriptyline or venlafaxine concurrently with ECT had better response rates t…”
BackgroundMcGirr, A., Karmani, S., Arsappa, R., Berlim, M. T., Thirthalli, J., Muralidharan, K., & Yatham, L. N. (2016) · World Psychiatry · doi:10.1002/wps.20300 · Cited by 97
Lage, C., Wiles, K., Shergill, S. S., & Tracy, D. K. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1592-8 · Cited by 70
“The choice of correct MT threshold has been relatively underexplored in clinical rTMS protocols despite evidence to suggest that both age and medication exhibit significant effects on the MT. rTMS is known to be less effective among older participants (Figiel et al. 1998; Su et al. 2005).”
BackgroundTrevizol, A. P., Downar, J., Vila-Rodriguez, F., Thorpe, K. E., Daskalakis, Z. J., & Blumberger, D. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100349 · Cited by 70
Severity of Depression Predicts Remission Rates Using Transcranial Magnetic Stimulation
Grammer, G. G., Kuhle, A. R., Clark, C. S., Dretsch, M. N., Williams, K. A., & Cole, J. T. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00114 · Cited by 44
“(10) reported that patients with less severe depression have a greater response to rTMS treatment (10).”
BackgroundResultInfluential
Metadata
- Authors
- Su, T.-P., Huang, C.-C., & Wei, I.-H.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2005-07-15
- Volume
- 66
- Issue
- 07
- Pages
- 930-937
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1964381474
- Cited by
- 102
- References
- 0
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.